TV
Travere Therapeutics, Inc.
TVTX · NASDAQ
$62.76 -3.28% (-$2.13)
1M -3.77%
Market Cap $5.84B
P/E Ratio -
Div. Yield -
ROE 55.79%
Piotroski F-Score Moderate
5/9Valuation
0 /100
Expensive EV/EBITDA 4,103.24x
P/S 9.87x
P/B 238.00x
Growth
100 /100
Growing Rev. growth 64.89%
Book val. growth 38.90%
EPS growth N/A
Profitability
38 /100
Moderate Gross margin 94.41%
Net margin 7.35%
Op. margin 6.84%
Quality
9 /100
Poor ROIC 6.25%
ROE 55.79%
ROA 5.44%
Debt
15 /100
High Debt/Equity 25.16x
Current ratio 4.05x
Int. coverage -6.07x
Stability
23 /100
Unstable Beta 1.06x
Rev. volatility 39.40%
EPS volatility 143.54%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o TVTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Eric Dube
Employees
497
Headquarters
San Diego
Nadchodzące wydarzenia
29 PAŹ
Earnings
Upcoming earnings report